Market Overview

Global Blood Stream Infection Testing Market Forecast to 2025 - Featuring Cepheid, Thermo Fisher, Biomerieux, Siemens Healthcare, Alere, Abbott Labs, and more - ResearchAndMarkets.com

Share:

The "Global
Blood Stream Infection Testing Market Analysis 2017 - Forecast to 2025"

report has been added to ResearchAndMarkets.com's
offering.

Annual estimations and forecasts are provided from the year 2014 to 2025
for each given segment and sub segments. The report analyzes the market
by discussing market dynamics such as drivers, constraints,
opportunities, threats, challenges and other market trends.

Assessment of major trends with potential impact on the market during
the next five years, including a deep dive analysis of market
segmentation which comprises of sub markets, regional and country level
analysis. The report provides a comprehensive outlook about the market
share along with strategic recommendations based on the emerging
segments.

Competitive landscaping provides the recent activities performed by the
active players in the market. Activities such as product launch,
agreements, joint ventures, partnerships, acquisitions and mergers, and
other activities.

Key Topics Covered

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porter's Five Force Analysis

5 Blood Stream Infection Testing Market by Test Type

6 Blood Stream Infection Testing Market by Technology

7 Blood Stream Infection Testing Market by Product

8 Blood Stream Infection Testing Market by Application

9 Blood Stream Infection Testing Market by End User

10 Geographical Segmentation

11 Vendor Landscaping

12 Company Profiles

  • Cepheid
  • Thermo Fisher Scientific
  • Biomerieux Inc.
  • Siemens Healthcare
  • Becton, Dickinson and Company
  • Alere Inc.
  • Abbott Laboratories
  • C. R. Bard Inc.
  • Beckman Coulter Inc.
  • F. Hoffmann-LA Roche AG

For more information about this report visit https://www.researchandmarkets.com/research/xc67sr/global_blood?w=4

View Comments and Join the Discussion!